DE102004016495A1 - Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine - Google Patents

Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine Download PDF

Info

Publication number
DE102004016495A1
DE102004016495A1 DE102004016495A DE102004016495A DE102004016495A1 DE 102004016495 A1 DE102004016495 A1 DE 102004016495A1 DE 102004016495 A DE102004016495 A DE 102004016495A DE 102004016495 A DE102004016495 A DE 102004016495A DE 102004016495 A1 DE102004016495 A1 DE 102004016495A1
Authority
DE
Germany
Prior art keywords
concentration
yohimbine
loss
agent
during driving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE102004016495A
Other languages
German (de)
Inventor
Heino Honemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE102004016495A priority Critical patent/DE102004016495A1/en
Publication of DE102004016495A1 publication Critical patent/DE102004016495A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

Agent for preventing momentary sleep or loss of concentration, e.g. when driving or engaged in an occupation that requires high concentration, comprises a yohimbine preparation (I). ACTIVITY : Nootropic. CNS-Gen. No biological details given. MECHANISM OF ACTION : None given.
DE102004016495A 2004-04-03 2004-04-03 Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine Ceased DE102004016495A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE102004016495A DE102004016495A1 (en) 2004-04-03 2004-04-03 Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004016495A DE102004016495A1 (en) 2004-04-03 2004-04-03 Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine

Publications (1)

Publication Number Publication Date
DE102004016495A1 true DE102004016495A1 (en) 2005-10-20

Family

ID=35034100

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102004016495A Ceased DE102004016495A1 (en) 2004-04-03 2004-04-03 Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine

Country Status (1)

Country Link
DE (1) DE102004016495A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204245B1 (en) * 1999-09-17 2001-03-20 The Regents Of The University Of California Treatment of narcolepsy with immunosuppressants
US20020166135A1 (en) * 2000-12-20 2002-11-07 Waleh Nahid S. Modulators of the hypocretin system and methods of screening therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204245B1 (en) * 1999-09-17 2001-03-20 The Regents Of The University Of California Treatment of narcolepsy with immunosuppressants
US20020166135A1 (en) * 2000-12-20 2002-11-07 Waleh Nahid S. Modulators of the hypocretin system and methods of screening therefor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Biol. Psych. 1991, 29(4), S. 376-382 *
Brain Res. 1989, 500(1-2), S. 209-214 *
J. Pharm. Exp. Ther. 1990, 253(3), S. 1145-1152 *

Similar Documents

Publication Publication Date Title
GB2422545B (en) Sterilant system
SG137810A1 (en) Process for the preparation of polyether polyols
MX276488B (en) Regeneration of acid gas-containing treatment fluids.
BR0212203A (en) Diabetes Treatment Compositions & Processes
HK1160388A1 (en) Methods of diagnosing and treating complications of pregnancy
IL190796A (en) Compositions comprising nucleic acid encoding anti-osteoclastogenic protein
WO2003080566A3 (en) Hif hydroxylase inhibitors
DE502004012162D1 (en) ELECTROSTERLY STABILIZED AQUEOUS POLYURETHANE RESINS, PROCESS FOR THEIR PREPARATION AND THEIR USE
WO2007013666A3 (en) Anti-tumor agents comprising r-spondins
PL1957973T3 (en) A system and method for determining a time when the blood alcohol concentration has passed a threshold level
EP1808412A4 (en) Method for purifying aqueous alkaline solution
WO2006001911A3 (en) Crystal structure of the hepatocyte growth factor beta chain and methods of use
WO2005004795A3 (en) Compositions and methods for targeted drug delivery
TW200636606A (en) Method and apparatus for evaluating a proposed solution to a constraint problem
DE102004016495A1 (en) Agent for preventing momentary sleep or loss of concentration, e.g. during driving, comprises yohimbine
AP2144A (en) Method and arrangement for implementing minimum activity during discontinuous transmission.
DE202005000816U1 (en) Weakly alkaline water activation apparatus comprises several filters and activators, including rare earth ceramic activator which induces resonance in water and prevents it from combining with oxygen
WO2006052167A3 (en) Steel treatment for protection against rust
应小华 Lecture de chez la fleuriste de Jacques Prévert
吴敌 WinFast PX6600GT TDH WinFast A6600GT TDH
UA4341U (en) Lytic mixture for hibernation and hypothermia
胡舒静 Right of Way in the Wild
裴蓓 Forgiveness Boosts Health; Effect Varies with Age
杨行胜 Ameriean's Love for Pets
王丁 HP Pavilion PC w1118cl

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8131 Rejection